Howard Hughes Medical Institute’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-43,057
Closed -$5.99M 102
2017
Q2
$5.99M Buy
43,057
+14,749
+52% +$2.07M 1.09% 20
2017
Q1
$4.09M Buy
28,308
+7,346
+35% +$1.05M 0.75% 32
2016
Q4
$2.85M Buy
20,962
+1,183
+6% +$152K 0.65% 38
2016
Q3
$2.38M Sell
19,779
-3,943
-17% -$465K 0.61% 44
2016
Q2
$2.79M Buy
23,722
+265
+1% +$30.4K 0.94% 38
2016
Q1
$2.81M Sell
23,457
-1,160
-5% -$132K 0.62% 40
2015
Q4
$2.79M Buy
24,617
+2,711
+12% +$300K 0.42% 39
2015
Q3
$2.33M Buy
21,906
+4,878
+29% +$512K 0.44% 39
2015
Q2
$1.73M Buy
17,028
+1,786
+12% +$184K 0.37% 51
2015
Q1
$1.52M Buy
15,242
+4,881
+47% +$488K 0.21% 59
2014
Q4
$1.01M Buy
10,361
+1,028
+11% +$102K 0.27% 62
2014
Q3
$933K Buy
9,333
+4,910
+111% +$504K 0.21% 58
2014
Q2
$473K Sell
4,423
-28
-0.6% -$2.87K 0.08% 58
2014
Q1
$434K Sell
4,451
-189
-4% -$17.7K 0.06% 51
2013
Q4
$452K Buy
4,640
+115
+3% +$10.7K 0.07% 56
2013
Q3
$410K Sell
4,525
-229
-5% -$20K 0.06% 61
2013
Q2
$413K Buy
+4,754
New +$421K 0.14% 64

Other funds holding RNR

Howard Hughes Medical Institute's RNR Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of RenaissanceRe (RNR) in Q3 2017, closing a stake of 43,057 shares — an estimated $5.99M sold.

Howard Hughes Medical Institute first reported a position in RNR in Q2 2013 and held it in 17 quarters. The position peaked at $5.99M in Q2 2017. 325 funds tracked by Wall St. Rank hold RNR as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining RenaissanceRe position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 43,057 RenaissanceRe shares in Q3 2017, an estimated $5.99M.
  • Howard Hughes Medical Institute first reported a position in RenaissanceRe in Q2 2013 and held it in 17 quarters.
  • Howard Hughes Medical Institute's RenaissanceRe position peaked at $5.99M in Q2 2017.
  • 325 funds tracked by Wall St. Rank held RenaissanceRe as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.